Ambarella Inc: Form 10-Q for the period ended Jul 31, 2026
Filed with the SEC on Sep 4, 2026 and accepted by EDGAR at Sep 4, 2026, 13:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-05-01 to 2026-07-31 | $108.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2026-02-01 to 2026-07-31 | $208.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-05-01 to 2026-07-31 | $45.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2026-02-01 to 2026-07-31 | $87.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-05-01 to 2026-07-31 | $62.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2026-02-01 to 2026-07-31 | $121.0m | us-gaap:GrossProfit |
| Research and development | 3 months2026-05-01 to 2026-07-31 | $50.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2026-02-01 to 2026-07-31 | $108.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-05-01 to 2026-07-31 | $20.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2026-02-01 to 2026-07-31 | $39.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-05-01 to 2026-07-31 | −$8.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2026-02-01 to 2026-07-31 | −$27.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2026-05-01 to 2026-07-31 | $352.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2026-02-01 to 2026-07-31 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-05-01 to 2026-07-31 | −$6.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2026-02-01 to 2026-07-31 | −$24.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-05-01 to 2026-07-31 | −$0.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2026-02-01 to 2026-07-31 | −$0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-05-01 to 2026-07-31 | −$0.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2026-02-01 to 2026-07-31 | −$0.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-05-01 to 2026-07-31 | 44,005,576 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2026-02-01 to 2026-07-31 | 43,805,429 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2026-02-01 to 2026-07-31 | −$25.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2026-02-01 to 2026-07-31 | $10.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 6 months2026-02-01 to 2026-07-31 | $2.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-07-31 | $101.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-07-31 | $394.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-07-31 | $780.2m | us-gaap:Assets |
| Current liabilities | At period end2026-07-31 | $138.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-07-31 | $159.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-07-31 | $620.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-383365. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.